UBS Starts Depomed At Buy, Says Nucynta Has More Potential Than Market Thinks
February 09, 2016 at 10:51 AM EST
The share price of Depomed Inc (NASDAQ: DEPO) has appreciated 2.27 percent over the last one month, while rising almost 4 percent ...